Skip to content
CB
Company

Updated:

Codiak BioSciences, Inc.

Codiak BioSciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001659352, and its reported...

Overview

Codiak BioSciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001659352, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-03-10, it reported annual revenue of USD 22,935,000; net income of USD -37,157,000; total assets of USD 171,670,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Codiak BioSciences, Inc.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001659352

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2021USD$22.9M-$37.2M$171.7M$76.9M-$74.1M
FY2020USD$2.9M-$91.7M$151.3M$88.9M-$63.4M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
SC 13G—Form SC 13G
SC 13G—Form SC 13G
10-Q10-Q
8-K8-K
SC 13D—ARCH VENTURE FUND VIII, L.P. -- CODIAK BIOSCIENCES, INC. -- SCHEDULE 13D
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Codiak BioSciences, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Codiak BioSciences, Inc. | Cambridge Company | Altss